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The phytochemical reinvestigation from the heartwood of the extracts of Cordia glazioviana 
led to the isolation of four still undescribed hydroquinones derivatives designated as 
cordiaquinol D (1), cordiaquinol E (2), (10R)-10,11-dihydrofuran-1,4-dihydroxy-globiferin (3) 
and 2-[(1’E,6’E)-3’,8’-dihydroxy-3’,7’-dimethylocta-1’,6’-dienyl]-benzene-1,4-diol (4), along 
with the naphthoquinone 6-[(2’R)-2’-hydroxy-3’,6’-dihydro-2H-pyran-5’-yl]-2-methoxy-
7-methylnaphthalene-1,4-dione (5). Additionally, six previously known compounds 
were also isolated: rel-1,4-dihydroxy-8α,11α;9α,11α-diepoxy-2-methoxy-8aβ-methyl-
5,6,7,8,8a,9,10,10a-octahydro-10-antracenone (6), didehydroconicol (7), 1β,6β-dihydroxy-7-epi-
eudesm-3-ene (8), 1β,6β-dihydroxy-7-epi-eudesm-4(15)-ene (9), 10,11-dihydroxybisabolol (10), 
and hamanasal-A (11). The structures of the new compounds were assigned by high-resolution 
mass spectrometry (HRMS) and nuclear magnetic resonance (NMR) analyses. The relative 
stereochemistry of 3, 4, and 5 was improved by quantum mechanical calculations. Eight, out of 
the eleven isolated compounds (2-9), were tested through cellular viability and lipopolysaccharide 
(LPS)-induced inflammation assays against RAW 264.7 macrophage-like cells. Compounds 3-5 
exhibited a stronger effect on LPS-induced NO production (half-maximal inhibitory concentration 
(IC50) 50.34, 105.83, and 66.73 μM, respectively). 
Keywords: Cordia glazioviana, Boraginaceae, hydroquinones, naphthoquinones, anti-
inflammatory activity
Introduction
Plants of the genus Cordia (Boraginaceae) have been 
described as a prolific source of bioactive compounds.1 In 
fact, several Cordia species (C. dichotoma, C. latifolia, 
C. verbenacea, C. myxa, C. rothii, C. gharaf, C. obliqua, 
etc.) have been used in different traditional systems of 
medicine around the world such as the Ayurveda, Unani, 
and Siddha2 due to their ethnopharmacological properties: 
anti-inflammatory, antimicrobial, anthelmintic, analgesic, 
and diuretic.1
Despite the wealthy Brazilian biodiversity, the great 
traditional knowledge and acceptance of medicinal 
plants, in contrast to the increasing world demand for 
phytotherapeutics, the Brazilian herbal medicine market 
is still very modest. Nevertheless, it is worthwhile to 
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highlight that an anti-inflammatory product incorporative 
Cordia verbenacea essential oil, is found among the top 
20 pharmaceutical drugs marketed in Brazil in 2016.3 
Moreover, recent studies have evidenced the anti-
inflammatory potential of extracts and pure compounds 
from other Cordia species.4
Previous phytochemical studies5,6 on Cordia genus 
have reported the isolation of terpenoids, particularly 
sesquiterpenes and tr i terpenes,  meroterpenoid 
benzoquinones, and naphthoquinones as well as their 
respective hydroquinones. Furthermore, the anti-
inflammatory effect of sesquiterpenes,7 triterpenes,8 
hydroquinones,9 and naphthoquinones10 have been 
demonstrated.
Cordia glazioviana (Auxemma glazioviana), an endemic 
Brazilian plant, is largely widespread in the “caatinga” 
(the characteristic biome of northeastern Brazil).11 In folk 
medicine, the water decoction from its barks is indicated to 
the healing of small cuts and wounds.6 Previous reports6,12 
on C. glazioviana described the isolation of sesquiterpenes 
and terpenoids benzoquinones, as well as hydroquinones. 
Thus, encouraged by the new perspective, we decided to 
reinvestigate the extracts of C. glazioviana pursuing the 
isolation of anti-inflammatory natural chemical compounds.
Results and Discussion
Eleven meroterpenoid compounds including 
sesquiterpenes, hydroquinones, and naphthoquinones, 
five of which previously unreported (1-5), were isolated 
from the ethanol (EtOH) extract of the heartwood of 
C. glazioviana (Figure 1).
Compound 1 had its molecular formula established 
as C17H18O5 by high-resolution electrospray ionization 
mass spectrometry (HRESIMS) through the deprotonated 
molecule [M - H]- at m/z 301.1076 (calcd. m/z 301.1081). 
Its infrared (IR) spectrum indicated absorption bands for 
hydroxy (3405 cm-1), carbonyls (1698 and 1630 cm-1), 
and carbon-carbon double bonds (1490 and 1442 cm-1). 
The 1H  NMR (nuclear magnetic resonance) spectrum 
(Table 1) displayed signals for aldehyde dH 9.50 (s, H-11), 
aromatic dH 6.41 (s, H-3), methylidene dH 6.38 (s, H-6a), 
6.23 (s, H-6b), and vinyl dH 4.98 (d, J 17.2 Hz) and 4.97 
(d, J 11.0 Hz) to 2H-7 and 5.80 (dd, J 17.2, 11.0 Hz, H-8) 
protons. Additionally, also displayed proton signals for 
diastereotopic methylene dH 3.05 (d, J 17.1 Hz, H-9a) and 
2.85 (d, J 17.1 Hz, H-9b), a methine proton dH 3.94 (1H, 
s, H-10a), as well as methoxyl dH 3.93 (s, OMe-2) and the 
methyl groups dH 1.12 (s, Me-12). The 13C NMR spectrum 
displayed signals for 17 carbon atoms, assigned by 
heteronuclear single quantum correlation (HSQC) spectra 
into two methyls (including the methoxyl), two carbons 
sp3 hybridized (methylene and methine), two double bonds 
(terminal and vinyl), an aldehyde carbonyl at dC  195.5 
(C-11) and, comparatively, eight non-hydrogenated 
carbons, including a conjugated ketone carbonyl at dC 202.7 
(C-10), Table 1. 1H and 13C  NMR data analysis were 
consistent with a 2-methoxy-p-hydroquinone, a vinyl group 
and an α,β-conjugated propenal moiety. The heteronuclear 
multiple bond correlation (HMBC) spectrum showed 
correlations of the methylidene hydrogens at dH 6.38/6.23 
(2H-6) with the aldehyde carbonyl at dC 195.5 (C-11) and 
dC 55.4 (C-10a), and the proton at dH 3.94 (H-10a) with 
the carbon at dC 202.7 (C-10) supporting the propenal 
moiety at the alpha position of the ketone carbonyl. The 
stereocenter C-8a, bearing a methyl and a vinyl group, was 
supported by the HMBC correlations of the methylidene 
vinyl protons at dH 4.98/4.97 (2H-7) with the carbon at 
dC 42.8 (C-8a), and the methyl protons at dH 1.12 (Me-12) 
with the sp2 methine carbon at dC 143.3 (C-8). Additional 
HMBC correlations, as depicted in Figure 2, supported the 
suggested planar structure. The relative stereochemistry 
ascribed to the stereocenters C-8a (R*) and C-10a (R*) 
were determined based on the nuclear Overhauser spectrum 
(NOESY) correlations between H-10a and the Me-12 
(Figure 3) indicating that both vinyl and propenal moieties 
are cis-vicinally positioned, what is in agreement with 
previous compounds isolated from other Cordia species.5,6 
From the above data, the relative configuration of 1, named 
cordiaquinol D, was established as shown in Figure 3.
Compound 2 had the molecular formula assigned as 
C16H18O4 based on the deprotonated molecule [M - H]- at 
Figure 1. Structures of compounds 1-11.
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m/z 273.1129 (calcd. m/z 273.1132) in the HRESIMS 
spectrum. Its IR spectrum displayed absorption bands for 
hydroxy (3412 cm-1), carbonyls (1674 and 1631 cm-1), 
and aromatic ring (1467 cm-1). The 1H  NMR spectrum 
exhibited signals for aldehyde dH 9.81 (d, J 3.4 Hz, H-11), 
ortho-positioned protons at dH 7.07 (d, J  8.9  Hz, H-2) 
and 6.69 (d, J  8.9  Hz, H-3), two methines dH 2.68 (m, 
H-5) and 3.11 (d, J 11.0 Hz, H-10a), one methyl dH 0.88 
(s, Me-12), signals for diastereotopic methylene dH 3.07 
(d, J  17.1  Hz, H-9a) and 2.70 (d, J  17.1  Hz, H-9b), 
and a series of methylene protons at dH 1.28-1.97. The 
13C  NMR spectrum showed 16 carbon signals assigned 
by distortionless enhancement by polarization transfer 
(DEPT 135°) and HSQC spectra into one methyl, four 
methylenes, two methines, two hydrogenated benzene, 
and seven non-hydrogenated carbon atoms, two of which 
related to carbonyls at dC 205.7 (C-11) and 206.1 (C-10) 
for an aldehyde and a ketone, respectively. The 1H and 
13C NMR data were consistent with a 1,4-hydroquinone 
similar to 1, but bearing a third ring which could be formed 
from 1 by the cyclization at C-6/C-7. Similarly, to 1 the 
aldehyde and the ketone functions, as well as the methyl 












1 137.6 148.6 151.2
2 157.3 125.7 7.07 d (8.9) 117.2 6.62 d (8.7)
3 98.4 6.41 s 116.0 6.69 d (8.9) 115.1 6.54 d (8.7)
4 160.2 156.6 149.9
4a 127.0 117.6 127.3
5 146.8 46.5 2.68 m 135.4
6 139.0 6.38 s 
6.23 s
28.0 1.97 dd (13.4, 3.5) 
1.38 m
28.0 2.11 m 
2.06 m
7 114.7 4.98 d (17.2) 
4.97 d (11.0)
21.3 1.79 m 
1.69 m
25.1 2.30 d (12.2) 
1.90 td (12.2, 2.8)
8 143.3 5.80 dd (17.2, 11.0) 41.1 1.79 m 
1.69 m
121.4 5.04 t (8.5)
8a 42.8 37.2 143.5
9 34.4 3.05 d (17.1) 
2.85 d (17.1)
41.0 3.07 d (17.1) 
2.70 d (17.1)
28.1 3.40 d (14.0) 
2.91 d (14.0)
9a 110.7 128.7 128.6
10 202.7 206.1 83.2 6.67 dd (5.7, 3.6)
10a 55.4 3.94 s 57.1 3.11 d (11.0) 126.9 5.20 br s
11 195.5 9.50 s 205.7 9.81 d (3.4) 77.5 4.75 dd (12.0, 5,7) 
4.69 ddd (12.0, 3.6, 
2.8)
12 26.5 1.12 s 18.2 0.88 s 22.4 1.59 s
2-OMe 56.8 3.93 s 
s: singlet; d: doublet; t: triplet; m: multiplet; br s: broad singlet; dd: doublet of doublets; td: triplet of doublets; ddd: doublet of doublet of doublets.
Figure 2. COSY ( ) and HMBC (H → C) correlations of 1-5.
Figure 3. Stick and ball structures of 1-3 depicting the key NOESY 
correlations of 1-3.
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group were positioned at C-5, C-10, and C-8a, respectively, 
in agreement with the HBMC correlations as summarized 
in Figure 2. The NOESY spectrum acquired in pyridine 
(C5D5N), Figure S16, Supplementary Information (SI) 
section showed correlations of the β-oriented methyl group 
(Me-12) with the methine proton H-5 and with one proton 
of the diastereotopic methylene H-9β (dH 3.07 d, J 17.1 Hz), 
indicated an α-orientation for the aldehyde group, while 
the dipolar interaction of the aldehyde proton (H-11) with 
the methine proton H-5 and this with the diastereotopic 
methylene H-9α (dH 2.70 d, J  17.1  Hz) confirmed the 
α-orientation for the aldehyde function and trans-
configuration of H-10a relatively to the Me-12 (Figure 3). 
Thus, the structure of compound 2 was established and 
designated of cordiaquinol E.
The molecular formula of C16H18O3 of compound 3 
was deduced through the protonated molecule [M + H]+ 
at m/z  259.1418 (calcd. m/z 259.1429), as observed by 
HRESIMS. The 1H and 13C  NMR data were similar to 
those of the globiferin,13 but with the quinoid nucleus 
in the reduced form. This moiety was evidenced by the 
ortho-positioned hydrogens at dH 6.62 (d, J 8.7 Hz, H-2) 
and 6.54 (d, J  8.7  Hz, H-3) and the chemical shifts at 
dC 151.2 (C-1), 117.2 (C-2), 115.1 (C-3), 149.9 (C-4), 
127.3 (C-4a) and 128.6 (C-9a) related to the benzenoid 
ring. Based on the 1H and 13C  NMR data (Table 1) in 
comparison with those of globiferin,13 the structure of 
3 was assigned 10,11-dihydrofuran-1,4-dihydroxy-
globiferin. Interpretation of the NOESY spectrum, assisted 
by the three-dimensional molecular structure of 3 built 
by molecular model, showed correlations for the dH 1.59 
(Me-12) with dH 3.40 (d, J 14.0 Hz, H-9) and dH 5.04 (t, 
J 8.5 Hz, H-8), between dH 5.20 (br s, H-10a) and dH 1.90 
(td, J 12.2, 2.8 Hz, H-7), and among the protons dH 2.11 
(m, H-6), dH 2.91 (d, J  14.0 Hz, H-9) and dH 4.75 (dd, 
J 12.0, 5.7 Hz, H-11) suggesting an R-configuration for 
the stereocenter-C10 which was supported by theoretical 
calculation methods. For the isomers 3a (10S) and 3b 
(10R), the calculated 13C chemical shift (dCcalc) values 
were determined using gauge independent atomic orbital 
(GIAO)14 method with mPW1PW91/6-31G(d,p) level of 
theory whose predicted values are reported in Table  2 
in comparison to the experimental 13C chemical shifts 
(dCexp). The results obtained (Figure 4) indicated that the 
coefficients of determination (R2) between the calculated 
and experimental data from linear regression analysis 
were 0.9927 (Figure 4a) and 0.9947 (Figure 4b) for 3a and 
3b, respectively, suggesting 3b (10R) as the presumable 
Table 2. Calculated 13C nuclear magnetic shielding (dCcalcd) using GIAO method with mPW1PW91/6-31G(d,p) level of theory for isomers 3a (10S)/3b 
(10R), and 5a (2’S)/5b (2’R) and 13C NMR experimental data (dCexp)
C dCexp
dCcalcd dCcalcd ΔdCa ΔdCa
C dCexp
dCcalcd dCcalcd ΔdCa ΔdCa
3a (S) 3b (R) 3a 3b 5a (S) 5b (R) 5a 5b
1 151.2 145.4611 144.6314 5.7389 6.5686 1 181.3 181.7422 181.6627 -0.4422 -0.3627
2 117.2 108.9535 110.7789 8.2465 6.4211 2 162.3 155.7953 155.8319 6.5047 6.4681
3 115.1 109.2763 109.7169 5.8237 5.3831 3 110.8 113.4709 113.3995 -2.6709 -2.5995
4 149.9 140.7750 144.7028 9.1250 5.1972 4 186.5 181.9432 182.0051 4.5568 4.4949
4a 127.3 127.8443 125.4793 -0.5443 1.8207 5 127.5 122.6102 121.9106 4.8898 5.5894
5 135.4 138.3312 141.4512 -2.9312 -6.0512 6 147.1 143.5774 143.8816 3.5226 3.2184
6 28.0 30.0751 26.9964 -2.0751 1.0036 7 143.9 140.2711 139.6327 3.6289 4.2673
7 25.1 35.5280 30.1266 -10.428 -5.0266 8 129.3 128.1594 128.2636 1.1406 1.0364
8 121.4 122.2173 118.9525 -0.8173 2.4475 9 131.4 126.4381 126.0063 4.9619 5.3937
8a 143.5 141.0534 138.1829 2.4466 5.3171 10 131.4 125.7014 125.7225 5.6986 5.6775
9 28.1 33.3114 31.9102 -5.2114 -3.8102 11 20.4 22.8705 22.9907 -2.4705 -2.5907
9a 128.6 122.0950 124.1246 6.5050 4.4754 2’ 92.4 88.4461 93.0382 3.9539 -0.6382
10 83.2 85.6513 83.3143 -2.4513 -0.1143 3’ 32.6 32.3276 32.4575 0.2724 0.1425
10a 126.9 127.0580 120.2239 -0.1580 6.6761 4’ 123.9 123.9666 127.899 -0.0666 -3.999
11 77.5 78.4126 78.4776 -0.9126 -0.9776 5’ 137.8 136.0568 135.1095 1.7432 2.6905
12 22.4 31.9853 23.5382 -9.5853 -1.1382 6’ 64.9 60.6239 67.1126 4.2761 -2.2126
2-OMe 57.3 60.0429 60.0452 -2.7429 -2.7452
sDP4+ / % 








sDP4+ / %  








aΔd = dCexp - dCcalcd: calculated 13C nuclear magnetic shielding deviation. sDP4+: scaled DP4+; uDP4+: unscaled DP4+; DP4+: direct probability 4.
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compound. To confirm this statement, a complementary 
analysis using DP4+ modified probability analysis was 
performed.15 Based on the unscaled DP4+ (uDP4+), scaled 
DP4+ (sDP4+), and DP4+ probabilities, the isomer  3b 
(Table 2) was confirmed. Thus, the structure of 3 was 
established as (10R)-10,11-dihydrofuran-1,4-dihydroxy-
globiferin.
The molecular formula for compound 4 (C16H22O4) 
was deduced by a combination of the 1H and 13C NMR 
spectra (Table 3) and the HRESIMS data, which 
exhibited a protonated ion peak at m/z 243.1381 (calcd. 
m/z  243.1380) corresponding to the loss of two H2O 
molecules [M  +  H  -  2H2O]+ in comparison with the 
original molecular formula. The 1H  NMR spectrum 
revealed signals of an ABC system for a monosubstituted 
1,4-hydroquinone moiety at dH 6.54 (d, J  8.4 Hz, H-6), 
6.53 (dd, J 8.4, 2.1 Hz, H-5) and 6.44 (d, J 2.1 Hz, H-3), 
a trans-disubstituted double bond dH 6.29 (d, J 16.4 Hz, 
H-1’) and 5.60 (d, J  16.4 Hz, H-2’), an E-trisubstituted 
double bond dH 5.25 (t, J 7.1 Hz, H-6’), as well as signals 
for methylene protons dH 4.02 (s, 2H-8’), 2.17 (m, 
2H-5’), and 1.64 (m, 2H-4’) and two methyls at dH 1.73 
(d, J 1.2 Hz, 3H-9’) and 1.31 (s, 3H-10’). The 13C NMR 
displayed 16 carbon atoms, whose hydrogenation patterns 
were defined, through DEPT 135º and HSQC spectra, into 
six monohydrogenated sp2 carbon, three methylenes, two 
methyls, five non-hydrogenated sp2 carbon atoms, including 
an oxygenated tertiary carbon (Table 3). According to 1H 
and the 13C NMR data, the difference between 4 and its 
analogous compound 2-(2Z)-(3-hydroxy-3,7-dimethylocta-
Figure 4. Optimized geometries and coefficient of determination between the experimental chemical shifts (dCexp) versus calculated chemical shifts (dCcalc) 
of isomers of compound 3 (10S (3a) and 10R (3b)) corresponding to figures (a) and (b), respectively.
Table 3. 1H (500 MHz, MeOD) and 13C NMR (125 MHz, MeOD) data 











3 113.9 6.44 d (2.1) 110.8 6.20 s
4 152.2 186.5
5 117.6 6.53 dd (8.4, 2.1) 127.5 7.71 s
6 116.5 6.54 d (8.4) 147.1
7 143.9
8 129.3 7.86 s
9 131.4
10 131.4
11 20.4 2.44 s
1’ 124.1 6.29 d (16.4)
2’ 131.7 5.60 d (16.4) 92.4 5.22 t (4.3)
3’ 79.1 32.6 2.51 m
2.62 m
4’ 42.3 1.64 m 123.9 5.69 m
5’ 23.5 2.17 m 137.8
6’ 128.7 5.25 t (7.1) 64.9 4.43 ddd (16.0, 4.6, 2.1)
4.28 ddd (16.0, 4.6, 2.4)
7’ 135.9
8’ 61.4 4.02 s
9’ 21.6 1.73 d (1.2)
10’ 26.5 1.31 s
2-OMe 57.3 3.89 s
s: singlet; d: doublet; t: triplet; m: multiplet; dd: doublet of doublets; 
ddd: doublet of doublet of doublets.
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1,6-dienyl)-1,4-benzenediol16 was the oxymethylene 
moiety instead of the methyl group at C-7’. Thus, the 
structure of 4 was characterized as the new geranylated 
hydroquinone designated as 2-[(1’E,6’E)-3’,8’-dihydroxy-
3’,7’-dimethylocta-1’,6’-dienyl]-benzene-1,4-diol.
The molecular formula C17H15O5 assigned to compound 5 
was determined through the deprotonated molecule [M - H]- 
at m/z 299.0920 (calcd. 299.0925). The 1H NMR spectrum 
displayed signals at dH 7.86 (s, H-8), 7.71 (s, H-5), 6.20 (s, 
H-3), 3.89 (s, OMe-2) and 2.44 (s, Me-11) of a 2-methoxy-
1,4-naphthoquinone moiety bearing a methyl group. 
Additional signals at dH 5.69 (m, H-4’), 5.22 (t, J 4.3 Hz, 
H-2’), 4.43 (ddd, J  16.0, 4.6, 2.1  Hz, H-6’)/4.28 (ddd, 
J 16.0, 4.6, 2.4 Hz, H-6’) and 2.51 (m, H-3’)/2.62 (m, H-3’) 
correlating with the carbons at dC 123.9, 92.4, 64.9 and 32.6, 
respectively, were suggestive of a 3’,6’-dihydro-2H-pyran-
2’-ol moiety. The 13C  NMR attached proton test (APT) 
spectrum exhibited 17 carbon signals further classified by 
HSQC spectra into two methyls, two methylenes, including 
an oxymethylene, five monohydrogenated carbons (being a 
hemiketal and four sp2 carbon), and eight non-hydrogenated 
carbon atoms (Table 3). The 2-methoxy-naphthoquinone 
framework bearing a 3’,6’-dihydro-2H-pyran-2’-ol moiety 
at C-6 was confirmed by the long-range correlations of H-5 
with the non-hydrogenated olefinic carbon at dC 137.8 (C-5’). 
The relative configuration of the ketal C-2’ as R (5b) was 
suggested based on theoretically calculated 13C chemical shift 
(dCcalc) values in comparison to the experimental 13C chemical 
shifts (dCexp), Table 3. The coefficients of determination (R2) 
of 0.9962 (Figure 5a) and 0.9967 (Figure 5b) were found for 
the stereoisomers 5a and 5b, respectively, including uDP4+, 
sDP4+ and DP4+ probabilities values15 (Table 2), suggest 5b 
(2’R) as the most plausible compound. Indeed, the H-2’ 
splitting as a triplet dH 5.22 (J 4.3 Hz) due to the similar 
J values for the axial/equatorial and equatorial/equatorial 
coupling is in accordance with the suggested stereochemistry 
through the theoretical calculation. In addition, the 13C NMR 
chemical shift of C-2’ at dC 92.4 is in agreement with the 
axial-position (dC 90.7) of the hydroxyl versus the equatorial-
position (dC 96.0) as previously observed for compound 13 
(rel-2’’-methoxy-7’’-methyl-1’’,4’’-naphtalendione-
(6’’→5)-tetrahydropyran-(2eq→O→2ax)-tetrahydropyran-
(5’→6’’’)-2’’’-methoxy-7’’’) in Pessoa et al.17 A similar 
effect of the 13C NMR shielding of axial hydroxy versus 
equatorial hydroxy is also observe for the anomeric carbons 
of α (dC 92.9) and β (dC 96.7) glucopyranose.18 Hence, 
the structure of 5 was stablished as 6-[(2’R)-2’-hydroxy- 
3’,6’-dihydro-2H-pyran-5’-yl]-2-methoxy-7-methyl-
naphthalene-1,4-dione (5).
F u r t h e r m o r e ,  t h e  f o l l o w i n g  k n o w n 




3-ene (8),20 1β,6β-dihydroxy-7-epi-eudesm-4(15)-ene 
(9),21 10,11-dihydroxybisabolol (10),22 and hamanasal-A 
(11)23 (see Figure 1).
Although there is no experimental support for the 
biosynthesis of the meroterpenoid 1,4-quinones isolated 
specifically from Cordia species, a reasonable biosynthetic 
Figure 5. Optimized geometries and coefficient of determination between the experimental chemical shifts (dCexp) versus calculated chemical shifts (dCcalc) 
of isomers of compound 5 (2’S (5a) and 2’R (5b)) corresponding to figures (a) and (b), respectively. 
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pathway for compounds 1 to 6 was suggested based on 
previous studies reported to terpenoid quinones.24 Thus, it 
seems reasonable that compounds 1-6 could be produced 
from a C-alkylation of the p-hydroxybenzoic acid with two 
prenyl unities followed by a sequence of typical reactions 
of the biogenetic process as intramolecular cyclization, 
oxidation, hydroxylation, and O-methylation as depicted 
in Figure 6.
3-(4 ,5-Dimethyl-2- th iazolyl ) -2 ,5-diphenyl-
2H-tetrazolium bromide (MTT) assay was carried out to 
evaluate the cytotoxic effects of the compounds on murine 
macrophages RAW 264.7 cells.25 As shown in Table 4, 
the compounds demonstrated a reduction of the cellular 
viability with half-maximal inhibitory concentration (IC50) 
values between 71.66-1530.02 μM. The concentrations of 
6.125, 12.5, 25, and 50 μM of compounds (no cytotoxicity 
on RAW264.7 cells) were selected for the subsequent 
experiments in the present study.
To evaluate the effects of the isolated compounds on 
the production of sulfated polysaccharides (LPS)-induced 
oxide nitric (NO) in RAW264.7 cells, the concentrations 
of NO in the culture medium were measured by the 
Griess assay.26 NO levels in the culture supernatants from 
LPS-stimulated cells were significantly reduced after 
treatment with the compounds (Table 4). Compounds 3, 
4, and 5 were more able to reduce NO production 
with IC50 values of 50.34  ±  9.88, 105.83 ± 5.09, and 
66.73 ± 10.28 μM, respectively.
Conclusions
Eleven compounds, including four new terpenoid 
hydroquinones (1-4) and a naphthoquinone (5), were 
isolated through the reinvestigation of the EtOH extract 
from the heartwood of C. glazioviana. It is worth 
highlighting that similar meroterpenoid compounds have 
been previously isolated from several Cordia species, and 
they seem to be restricted to woody plants, in particular, 
in the roots and trunk heartwood. As a significant number 
of terpenoid quinones and hydroquinones were previously 
isolated from Cordia species, it seems reasonable to suggest 
these compounds as possible chemomarkers for the genus. 
Eight, out of the eleven isolated compounds (2-9), were 
tested through cellular viability and lipopolysaccharide 
(LPS)-induced inflammation assays against RAW 
264.7 macrophage-like cells, being compound 3 the 




Optical rotations were measured on a Jasco P-2000 
polarimeter (Tokyo, Japan), operating with a tungsten lamp 
at a wavelength of 589 nm at 20 °C. Melting points were 
recorded on a digital Marconi MA-381 (Piracicaba, Brazil) 
apparatus and were uncorrected. Fourier-transform infrared 
(FTIR) spectra were obtained on a PerkinElmer Spectrum 
100 spectrometer (Waltham, USA), using a universal 
attenuated total reflectance accessory (UATR). The high-
resolution mass spectra (HRMS) analysis was acquired on 
a chromatograph coupled to an ion trap mass spectrometer 
and time-of-flight (LCMS-IT-TOF, Shimadzu, Kyoto, Japan) 
system as well as on an Acquity UPLC instrument coupled 
to a Xevo QToF mass analyzer (Waters, Milford, MA, USA). 
1H and 13C NMR (1D and 2D) spectra were run on a Bruker 
Avance DRX-500 spectrometer, using MeOD and C5D5N 
Table 4. Effects of compounds 2-9 on cell viability and inhibiting nitric 
oxide production in activated RAW264.7 macrophage cells
Compound Cytotoxicity IC50a / µM NO inhibition IC50a / µM
2 158.38 ± 11.05 1420.72 ± 4.63
3 71.66 ± 15.44 50.34 ± 9.88
4 424.82 ± 6.46 105.83 ± 5.09
5 166.25 ± 6.79 66.73 ± 10.28
6 609.48 ± 5.05 143.64 ± 4.67
7 1530.02 ± 4.54 197.68 ± 3.84
8 157.20 ± 6.63 292.04 ± 3.64
9 355.70 ± 10.67 235.50 ± 3.18
Dexamethasoneb 1.79 ± 0.04
aHalf-maximal inhibitory concentration (IC50) values are represented as 
means ± standard deviation of three independent experiments; bpositive 
control.
Figure 6. Plausible biogenetic pathways for compounds 1-6.
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(Cambridge Isotope Laboratories Inc., Tewksbury, USA) 
as solvents. The high-performance liquid chromatography 
(HPLC) separations were achieved on a Shimadzu-UFLC 
semi-preparative HPLC system, equipped with ternary 
pumps and diode array SPD-M20A UV/VIS detector using 
a Phenomenex C18 column (Phenomenex, Torrance, USA) 
(250 × 10 mm, 5 mm) and a mobile phase consisting of water 
was purified in a Milli-Q system (Millipore, St. Louis, USA) 
with trifluoroacetic acid (CF3CO2H, 0.1% v/v) analytical 
grade was acquired from Vetec (Rio de Janeiro, Brazil) and 
acetonitrile (MeCN) HPLC grade, were purchased from Tedia 
(Rio de Janeiro, Brazil), a flow rate of 4.7 or 4.0 mL min–1, 
oven temperature of 40  °C, monitored at 210-400  nm. 
Chromatography columns (CC) were performed using 
silica gel 60 (70-230 mesh, Vetec, Rio de Janeiro, Brazil), 
while the analytical thin-layer chromatography (TLC) was 
carried out on pre-coated TLC silica gel plates (Merck, 
Frankfurt, Germany) and the spots visualized by spraying 
with a vanillin/perchloric acid/EtOH (Vetec, Rio de Janeiro, 
Brazil and Merck, Frankfurt, Germany) solution followed 
by heating at 100 °C. All PA solvents were purchased from 
Labsynth (São Paulo, Brazil).
Plant material
Cordia glazioviana was collected in April 2012 at 
Acarape county, Ceará State, Brazil and was authenticated 
by Dra Maria Iracema Bezerra Loiola, botanist of 
Departamento de Biologia, Universidade Federal do Ceará 
(UFC). A voucher specimen (No. 30824) is deposited at 
the Herbário Prisco Bezerra-UFC. The collection permit 
was granted by Biodiversity Authorization and Information, 
SisGen number A86B918.
Extraction and isolation
The air-dried and milled heartwood (2.7 kg) of 
C. glazioviana was macerated with EtOH (3 × 10 L), at 
room temperature for 24 h and the resulting solutions 
were destilled under reduced pressure to yield 91.8 g of 
the crude extract. The EtOH extract was solubilized in a 
mixture of MeOH-H2O 2:1 and partitioned with n-hexane, 
dichloromethane (CH2Cl2) and ethyl acetate (EtOAc) to 
yield the respective fractions: CGH (21.8 g), CGD (26.7 g) 
and CGA (7.5 g). The CGD fraction was fractioned on a 
silica gel column (55.1 g) eluting with n-hexane-EtOAc 
(8:2, 6:4, 4:6, 2:8, v/v), EtOAc-MeOH (8:2, 6:4, v/v) and 
MeOH, to yield fractions CGDF1-F7. CGDF1 (900.0 mg) 
was subjected to a silica gel CC eluted with n-hexane, 
n-hexane-EtOAc (9.5:0.5, 9:1, 8:2, 7:3, 6:4, 1:1, v/v) and 
EtOAc to afford 51 fractions (20 mL each), which were 
pooled into 5 main subfractions (CGDF1a-CGDF1e) after 
TLC analysis. CGDF1a (91.2 mg) was subjected to a flash 
chromatography column eluted with n-hexane-EtOAc 1:1 
(v/v) to yield compound 10 (6.0 mg). CGDF1b (78.0 mg) 
was purified by HPLC using a semi-preparative column 
and an isocratic solvent system of H2O-MeCN 1:1 at a 
flow rate of 4.5 min-1 to afford 8 (8.0 mg, retention time 
(tR) 10.2  min) and 9 (10.1 mg, tR 15.9 min). CGDF1d 
(106.1 mg) was applied to a silica gel column and eluted 
with n-hexane-CH2Cl2 (8:2, 6:4, 4:6, 2:8, v/v), CH2Cl2, 
CH2Cl2-EtOAc (9:1, 7:3, 1:1, 3:7, 1:9, v/v) and EtOAc 
to give 83 fractions of 8 mL each, pooled into 6 main 
fractions after TLC analysis. Fraction n-hexane-CH2Cl2 
(4:6, v/v), afforded compound 11 (16.2 mg). CGDF2 
(2.1 g) was subjected to a silica gel column eluted with 
n-hexane, n-hexane-EtOAc (9.5:0.5, 9:1, 8:2, 7:3, 6:4, 
v/v) and EtOAc, to yield fractions CGDF2a-CGDF2f after 
TLC monitoring. Fraction CGDF2c (1.0 g) was fractioned 
over silica gel by elution with n-hexane-CH2Cl2 (9:1, 8:2, 
7:3, 6:4, 1:1, 4:6, 3:7, 2:8, v/v) and CH2Cl2 to yield 70 
fractions, which were pooled into 7 subfractions. HPLC 
analysis of subfraction n-hexane-CH2Cl2 7:3 (171.0 mg) 
on a C18 semi-preparative column using a solvent system 
gradient (H2O-MeCN 1:1→3:7 in 20 min) at a flow rate 
of 4.5 min-1, to yield compound 7 (2.4 mg, tR 13.2 min). 
CGDF2d (1.1 g) was chromatographed over silica gel 
and eluted with n-hexane-CH2Cl2 (8:2, 6:4, 4:6, 2:8, v/v), 
CH2Cl2, CH2Cl2-EtOAc (8:2, 6:4, v/v) to give 68 fractions 
(30 mL each), which were pooled into 5 main fractions 
(CGDF2d1-CGDF2d5) after TLC analysis. CGDF2d2 was 
chromatographed over silica gel, eluting with n-hexane-
CH2Cl2 (8:2, 6:4, 4:6, 2:8, v/v), CH2Cl2, CH2Cl2-EtOAc 
(8:2, 6:4, 4:6, v/v) to yield 77  fractions (5 mL each), 
which were combined according to their TLC profile in 
4 subfractions. Subfraction 1 (150.2 mg) was analyzed by 
HPLC using a C18 semi-preparative column and an aqueous 
solution of 0.1% CF3CO2H in MeCN (65:35→40:60 in 
25  min) as eluent, with a flow rate of 4.0  mL min-1, to 
yield 6 (5.3 mg, tR 15.9 min) and 2 (6.1 mg, tR 17.3 min). 
The subfraction 4 (81.7 mg) was fractioned over silica 
eluted with n-hexane-CH2Cl2 (1:1, 4:6, 3:7, 2:8, 1:9, 
v/v), CH2Cl2, CH2Cl2-EtOAc (9:1, 8:2, 7:3 v/v) to afford 
compound 1 (10.0 mg) from subfraction n-hexane-CH2Cl2 
(2:8). CGDF2e (350.0 mg) was chromatographed on a 
silica gel column eluting with n-hexane-CH2Cl2 (7:3, 
1:1, 3:7, 1:9, v/v) and CH2Cl2/EtOAc (9:1, 7:3, 1:1, v/v) 
to yield subfractions CGDF2e1-CGDF2e7. Compound 3 
(12.0 mg) was isolated from CGDF2e7, while 4 (6.0 mg, 
tR 11.5 min) was obtained from subfraction CGDF2e6 
(176.5 mg) after C18 semipreparative HPLC (H2O-MeCN 
6:4). The CGA fraction (7.5 g) was fractionated on a silica 
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gel column eluted with n-hexane-EtOAc (8:2, 7:3, 6:4, 1:1, 
4:6, 3:7 and 2:8, v/v) to yield CGAF1-CGAF7. CGAF2 was 
subjected to a silica gel CC eluted with n-hexane-EtOAc 
(9:1, 8.5:1.5, 8:2, 7.5:2.5, 7:3, 6:4, 1:1, 4:6 and 3:7) to 
afford 147 subfractions (8 mL each). Subfractions 125-142 
(114.6 mg) was subjected to a flash chromatography using 
n-hexane-EtOAc 4:6 and further purified by HPLC using 
a C18 semi-preparative column with the solvent system 
H2O-MeCN (75:25→55:45 in 20 min) and a flow rate of 
4.0 mL min-1 to afford compound 5 (9.8 mg, tR 17.2 min). 
Computational details
To establish the relative stereochemistry of compounds 3 
and 5, two possible isomers of each one of those 
compounds  (3a/3b and 5a/5b) were drawn and their 
geometrical structures were optimized by using standard 
techniques.27 Optimization calculations were performed 
by using density functional theory (DFT)28 method and a 
functional version of the PW91 exchange in combination 
with the original PW91 correlation functional and a mixing 
ratio of exact and DFT exchange of 0.25:0.75, mPW1PW9129 
along with 6-31G(d,p) basis set implemented in Gaussian 16 
package.30 The frequencies of the optimized geometries were 
calculated to determine whether the resulting geometries 
were true minima or transition states on the potential energy 
surface. All optimization calculations were performed in 
solution by using the polarizable continuum model (PCM)31 
with the integral equation formalism (IEF)32 using methanol 
as solvent. The NMR isotropic shielding constants were 
determined from the optimized geometries of 3a/3b and 
5a/5b with mPW1PW91/6-31G(d,p) level of theory based 
on the GIAO14 proposal with tetramethylsilane (TMS) as 
reference implemented in the Gaussian 16.30 The integral 
equation formalism and polarizable continuum model (IEF-
PCM) solvation method was used with methanol (the solvent 
used to acquire the 1H and 13C NMR spectra) as an implicit 
solvent to simulate the medium on the chemical shifts of the 
stereoisomers. A supplemental analysis that correlates NMR 
chemical shifts and statistical analysis, named DP4+ allows 
the use of quantum chemical calculated NMR parameters 
combined with refined statistical data to elucidate the most 
likely structure among the stereoisomers.15
Assay for cell viability
Cell viability was assessed using the MTT (Sigma-
Aldrich, St. Louis, USA) assay as described previously.25 In 
brief, RAW 264.7 cells (Merck, Frankfurt, Germany) were 
seeded into a 96-well plate at a density of 1 × 104 cells per 
well and incubated at 37 °C for 24 h. Compounds at 
different concentrations (12.5-100 μM) in dimethyl 
sulfoxide (DMSO, Romil Chemical Ltd., Cambridge, UK) 
were added to the cell plate for another 24 h, and then MTT 
(0.5 mg mL-1) in phosphate-buffered saline (PBS, Merck, 
Frankfurt, Germany) was added into each well to form the 
formazan crystals (3 h). The supernatant was then carefully 
removed, and 100 μL of DMSO was added into each well 
to dissolve the MTT formazan crystals and measured at 
540 nm using a microplate reader. 
Assay for the inhibition of cellular NO production
The nitrite concentration in the medium was measured 
by the Griess reagent as an indicator of NO production.26 
RAW 264.7 cells were seeded into a 96-well plate at a 
density of 5 × 105 cells per well and incubated at 37 °C for 
24 h. After that, the cells were treated with several sample 
concentrations (6.25-50 μM) or controls (0.01% DMSO 
or 4 μM dexamethasone) for 2 h and then incubated with 
1 μg mL-1 LPS for 24 h. To measure the NO in the culture 
medium, a total of 100 µL of culture medium from each 
sample was mixed with the same volume of Griess reagent 
and incubated at 37 °C for 10 min. The absorbance was 
measured at 540 nm using a microplate reader.
Cordiaquinol D (1)
Yellow resin; [α]D20 -22.0 (c 0.1, MeOH); IR (ATR) 
νmax / cm-1 3405, 1698, 1630, 1490, 1442, 1362, 1292, 1222, 
929, 881; 1H and 13C NMR data, see Table 1; HRESIMS 
m/z, calcd. for C17H17O5 [M - H]-: 301.1081, found: 
301.1076.
Cordiaquinol E (2)
Yellow resin; [α]D20 +16.0 (c 0.1, acetone); IR (ATR) 
νmax / cm-1 3412, 1674, 1631, 1467, 1257, 1214; 1H and 
13C  NMR data, see Table 1; HRESIMS m/z, calcd. for 
C16H17O4 [M - H]-: 273.1132, found: 273.1129.
(10R)-10,11-Dihydrofuran-1,4-dihydroxy-globiferin (3)
Yellow resin; [α]D20 +2.7 (c 0.06, acetone); IR (ATR) 
νmax / cm-1 3362, 1649, 1466, 1264, 780, 703; 1H and 
13C  NMR data, see Table 1; HRESIMS m/z, calcd. for 
C16H19O3 [M + H]+: 259.1429, found: 259.1418.
2-[(1’E,6’E)-3’,8’-Dihydroxy-3’,7’-dimethylocta-1’,6’-dienyl]-
benzene-1,4-diol (4)
Colorless resin; [α]D20 +9.2 (c 0.1, acetone); IR (ATR) 
νmax / cm-1 3307, 2967, 2918, 1484, 1456, 1203, 955, 918, 
763, 711; 1H and 13C  NMR spectral data, see Table  3; 
HRESIMS m/z, calcd. for C16H19O2 [M + H - 2H2O]+: 
243.1380, found: 243.1381. 
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6-[(2’R)-2’-Hydroxy-3’,6’-dihydro-2H-pyran-5’-yl]-2-methoxy-
7-methylnaphthalene-1,4-dione (5)
Yellow resin; [α]D20 -16.0 (c 0.1, MeOH); IR (ATR) 
νmax / cm-1 3411, 2927, 1683, 1649, 1606, 1295, 1250, 906, 
852; 1H and 13C NMR data, see Table 3; HRESIMS m/z, 
calcd. for C17H15O5 [M - H]-: 299.0925, found: 299.0920. 
Supplementary Information
Supplementary data are available free of charge at 
http://jbcs.sbq.org.br as a PDF file.
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